{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T10:51:12Z","timestamp":1792234272384,"version":"4.4.0"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1016\/j.biomaterials.2015.11.016","type":"journal-article","created":{"date-parts":[[2015,11,10]],"date-time":"2015-11-10T06:39:46Z","timestamp":1447137586000},"page":"243-254","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":88,"special_numbering":"C","title":["Hitchhiking nanoparticles: Reversible coupling of lipid-based nanoparticles to cytotoxic T lymphocytes"],"prefix":"10.1016","volume":"77","author":[{"given":"Laura","family":"Wayteck","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heleen","family":"Dewitte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynn","family":"De Backer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karine","family":"Breckpot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo","family":"Demeester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefaan C.","family":"De Smedt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koen","family":"Raemdonck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biomaterials.2015.11.016_bib1","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.addr.2013.11.009","article-title":"Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology","volume":"66","author":"Bertrand","year":"2014","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.biomaterials.2015.11.016_bib2","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/nnano.2007.387","article-title":"Nanocarriers as an emerging platform for cancer therapy","volume":"2","author":"Peer","year":"2007","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.biomaterials.2015.11.016_bib3","doi-asserted-by":"crossref","first-page":"3717","DOI":"10.1002\/adma.201202080","article-title":"Materials for drug delivery: innovative solutions to address complex biological hurdles","volume":"24","author":"Mitragotri","year":"2012","journal-title":"Adv. Mater."},{"key":"10.1016\/j.biomaterials.2015.11.016_bib4","doi-asserted-by":"crossref","first-page":"2971","DOI":"10.1039\/c2cs15344k","article-title":"Targeted polymeric therapeutic nanoparticles: design, development and clinical translation","volume":"41","author":"Kamaly","year":"2012","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.biomaterials.2015.11.016_bib5","first-page":"467","article-title":"Targeted therapy using nanotechnology: focus on cancer","volume":"9","author":"Sanna","year":"2014","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.biomaterials.2015.11.016_bib6","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/wnan.143","article-title":"Overcoming in\u00a0vivo barriers to targeted nanodelivery","volume":"3","author":"Chrastina","year":"2011","journal-title":"Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol."},{"key":"10.1016\/j.biomaterials.2015.11.016_bib7","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.nantod.2014.04.008","article-title":"Challenges associated with penetration of nanoparticles across cell and tissue barriers: a review of current status and future prospects","volume":"9","author":"Barua","year":"2014","journal-title":"Nano Today"},{"key":"10.1016\/j.biomaterials.2015.11.016_bib8","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.addr.2012.10.002","article-title":"The EPR effect for macromolecular drug delivery to solid tumors: improvement of tumor uptake, lowering of systemic toxicity, and distinct tumor imaging in\u00a0vivo","volume":"65","author":"Maeda","year":"2013","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.biomaterials.2015.11.016_bib9","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1158\/0008-5472.CAN-12-4561","article-title":"Challenges and key considerations of the enhanced permeability and retention effect for nanomedicine drug delivery in oncology","volume":"73","author":"Prabhakar","year":"2013","journal-title":"Cancer Res."},{"key":"10.1016\/j.biomaterials.2015.11.016_bib10","doi-asserted-by":"crossref","first-page":"15549","DOI":"10.1073\/pnas.0707461104","article-title":"Impact of tumor-specific targeting on the biodistribution and efficacy of siRNA nanoparticles measured by multimodality in\u00a0vivo imaging","volume":"104","author":"Bartlett","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.biomaterials.2015.11.016_bib11","doi-asserted-by":"crossref","first-page":"6732","DOI":"10.1158\/0008-5472.CAN-05-4199","article-title":"Antibody targeting of long-circulating lipidic nanoparticles does not increase tumor localization but does increase internalization in animal models","volume":"66","author":"Kirpotin","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.biomaterials.2015.11.016_bib12","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1073\/pnas.0914140107","article-title":"Mechanism of active targeting in solid tumors with transferrin-containing gold nanoparticles","volume":"107","author":"Choi","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.biomaterials.2015.11.016_bib13","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.nantod.2011.04.001","article-title":"Enhancing cell therapies from the outside in: cell surface engineering using synthetic nanomaterials","volume":"6","author":"Stephan","year":"2011","journal-title":"Nano Today"},{"key":"10.1016\/j.biomaterials.2015.11.016_bib14","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1038\/gt.2008.38","article-title":"Cell vehicle targeting strategies","volume":"15","author":"Roth","year":"2008","journal-title":"Gene Ther."},{"key":"10.1016\/j.biomaterials.2015.11.016_bib15","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1084\/jem.20061890","article-title":"In\u00a0vivo imaging of cytotoxic T cell infiltration and elimination of a solid tumor","volume":"204","author":"Boissonnas","year":"2007","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.biomaterials.2015.11.016_bib16","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/nrc1367","article-title":"Exploiting tumour hypoxia in cancer treatment","volume":"4","author":"Brown","year":"2004","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.biomaterials.2015.11.016_bib17","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1016\/j.addr.2013.09.019","article-title":"Nanomedicine therapeutic approaches to overcome cancer drug resistance","volume":"65","author":"Markman","year":"2013","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.biomaterials.2015.11.016_bib18","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1182\/blood-2004-03-1109","article-title":"Mechanisms regulating the recruitment of macrophages into hypoxic areas of tumors and other ischemic tissues","volume":"104","author":"Murdoch","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.biomaterials.2015.11.016_bib19","doi-asserted-by":"crossref","first-page":"3759","DOI":"10.1021\/nl072209h","article-title":"A\u00a0cellular Trojan Horse for delivery of therapeutic nanoparticles into tumors","volume":"7","author":"Choi","year":"2007","journal-title":"Nano Lett."},{"key":"10.1016\/j.biomaterials.2015.11.016_bib20","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jconrel.2014.11.027","article-title":"Monocyte-mediated delivery of polymeric backpacks to inflamed tissues: a generalized strategy to deliver drugs to treat inflammation","volume":"199","author":"Anselmo","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.biomaterials.2015.11.016_bib21","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.coi.2009.03.002","article-title":"Adoptive cell therapy for the treatment of patients with metastatic melanoma","volume":"21","author":"Rosenberg","year":"2009","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.biomaterials.2015.11.016_bib22","doi-asserted-by":"crossref","first-page":"4550","DOI":"10.1158\/1078-0432.CCR-11-0116","article-title":"Durable complete responses in heavily pretreated patients with metastatic melanoma using T-cell transfer immunotherapy","volume":"17","author":"Rosenberg","year":"2011","journal-title":"Clin. Cancer. Res."},{"key":"10.1016\/j.biomaterials.2015.11.016_bib23","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.canlet.2013.09.016","article-title":"A personalized view on cancer immunotherapy","volume":"352","author":"Wayteck","year":"2014","journal-title":"Cancer Lett."},{"key":"10.1016\/j.biomaterials.2015.11.016_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.immuni.2013.07.012","article-title":"Oncology meets immunology: the cancer-immunity cycle","volume":"39","author":"Chen","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.biomaterials.2015.11.016_bib25","first-page":"866","article-title":"Therapeutic cell engineering using surface-conjugated synthetic nanoparticles","volume":"33","author":"Stephan","year":"2010","journal-title":"J.\u00a0Immunother."},{"key":"10.1016\/j.biomaterials.2015.11.016_bib26","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1038\/nm1297","article-title":"Tumor-targeted, systemic delivery of therapeutic viral vectors using hitchhiking on antigen-specific T cells","volume":"11","author":"Cole","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.biomaterials.2015.11.016_bib27","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1126\/scitranslmed.aaa5447","article-title":"Active targeting of chemotherapy to disseminated tumors using nanoparticle-carrying T cells","volume":"7","author":"Huang","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.biomaterials.2015.11.016_bib28","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.addr.2012.09.037","article-title":"Liposomal drug delivery systems: from concept to clinical applications","volume":"65","author":"Allen","year":"2013","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.biomaterials.2015.11.016_bib29","doi-asserted-by":"crossref","first-page":"363","DOI":"10.3389\/fimmu.2013.00363","article-title":"TCR-engineered T cells meet new challenges to treat solid tumors: choice of antigen, T cell fitness, and sensitization of tumor milieu","volume":"4","author":"Kunert","year":"2013","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biomaterials.2015.11.016_bib30","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1097\/CJI.0b013e31827806e6","article-title":"Sorting through subsets: which T-cell populations mediate highly effective adoptive immunotherapy?","volume":"35","author":"Klebanoff","year":"2012","journal-title":"J.\u00a0Immunother."},{"key":"10.1016\/j.biomaterials.2015.11.016_bib31","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1038\/leu.2013.285","article-title":"In vitro generation of mature, naive antigen-specific CD8(+) T cells with a single T-cell receptor by agonist selection","volume":"28","author":"Snauwaert","year":"2014","journal-title":"Leukemia"},{"key":"10.1016\/j.biomaterials.2015.11.016_bib32","doi-asserted-by":"crossref","first-page":"4435","DOI":"10.1021\/nl103264u","article-title":"Sizing nanomatter in biological fluids by fluorescence single particle tracking","volume":"10","author":"Braeckmans","year":"2010","journal-title":"Nano Lett."},{"key":"10.1016\/j.biomaterials.2015.11.016_bib33","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1002\/adfm.200801795","article-title":"Biodegradable dextran nanogels for RNA interference: focusing on endosomal escape and intracellular siRNA delivery","volume":"19","author":"Raemdonck","year":"2009","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.biomaterials.2015.11.016_bib34","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jconrel.2015.03.015","article-title":"Bio-inspired pulmonary surfactant-modified nanogels: a promising siRNA delivery system","volume":"206","author":"De Backer","year":"2015","journal-title":"J.\u00a0Control. Release"},{"key":"10.1016\/j.biomaterials.2015.11.016_bib35","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jconrel.2007.10.024","article-title":"A\u00a0fast and sensitive method for measuring the integrity of siRNA-carrier complexes in full human serum","volume":"126","author":"Buyens","year":"2008","journal-title":"J.\u00a0Control. Release"},{"key":"10.1016\/j.biomaterials.2015.11.016_bib36","doi-asserted-by":"crossref","first-page":"4001","DOI":"10.1073\/pnas.2628032100","article-title":"Lymphocyte surface thiol levels","volume":"100","author":"Sahaf","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.biomaterials.2015.11.016_bib37","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/smll.200901158","article-title":"Effect of surface properties on nanoparticle-cell interactions","volume":"6","author":"Verma","year":"2010","journal-title":"Small"},{"key":"10.1016\/j.biomaterials.2015.11.016_bib38","doi-asserted-by":"crossref","first-page":"5776","DOI":"10.1016\/j.biomaterials.2012.04.029","article-title":"Synapse-directed delivery of immunomodulators using T-cell-conjugated nanoparticles","volume":"33","author":"Stephan","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2015.11.016_bib39","first-page":"69","article-title":"Molecular and cellular aspects of thiol-disulfide exchange","volume":"63","author":"Gilbert","year":"1990","journal-title":"Adv. Enzymol. Relat. Areas Mol. Biol."},{"key":"10.1016\/j.biomaterials.2015.11.016_bib40","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1016\/j.cca.2011.11.006","article-title":"Surface markers of lymphocyte activation and markers of cell proliferation","volume":"413","author":"Shipkova","year":"2012","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.biomaterials.2015.11.016_bib41","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.tibtech.2011.12.002","article-title":"Exploiting cell surface thiols to enhance cellular uptake","volume":"30","author":"Torres","year":"2012","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.biomaterials.2015.11.016_bib42","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S0968-0004(03)00057-4","article-title":"Disulfide bonds as switches for protein function","volume":"28","author":"Hogg","year":"2003","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.biomaterials.2015.11.016_bib43","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1186\/1556-276X-6-283","article-title":"T\u00a0cells enhance gold nanoparticle delivery to tumors in\u00a0vivo","volume":"6","author":"Kennedy","year":"2011","journal-title":"Nanoscale Res. Lett."},{"key":"10.1016\/j.biomaterials.2015.11.016_bib44","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1016\/j.biomaterials.2009.01.026","article-title":"Reduction-sensitive polymers and bioconjugates for biomedical applications","volume":"30","author":"Meng","year":"2009","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2015.11.016_bib45","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1517\/17425240903427940","article-title":"Liposomal cancer therapy: exploiting tumor characteristics","volume":"7","author":"Kaasgaard","year":"2010","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.biomaterials.2015.11.016_bib46","first-page":"958","article-title":"Long circulating nanoparticles via adhesion on red blood cells: mechanism and extended circulation","volume":"232","author":"Chambers","year":"2007","journal-title":"Exp. Biol. Med. (Maywood)"},{"key":"10.1016\/j.biomaterials.2015.11.016_bib47","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jconrel.2006.06.032","article-title":"Applications of carrier erythrocytes in delivery of biopharmaceuticals","volume":"118","author":"Hamidi","year":"2007","journal-title":"J.\u00a0Control. Release"},{"key":"10.1016\/j.biomaterials.2015.11.016_bib48","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1517\/17425247.2.2.311","article-title":"Erythrocyte-based drug delivery","volume":"2","author":"Rossi","year":"2005","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.biomaterials.2015.11.016_bib49","doi-asserted-by":"crossref","first-page":"H105","DOI":"10.1002\/adma.201004074","article-title":"Cell-based drug delivery devices using phagocytosis-resistant backpacks","volume":"23","author":"Doshi","year":"2011","journal-title":"Adv. Mater."},{"key":"10.1016\/j.biomaterials.2015.11.016_bib50","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s12645-012-0029-9","article-title":"Delivery of nanoparticles to brain metastases of breast cancer using a cellular Trojan horse","volume":"3","author":"Choi","year":"2012","journal-title":"Cancer Nanotechnol."},{"key":"10.1016\/j.biomaterials.2015.11.016_bib51","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1021\/nn901319y","article-title":"Nanoparticulate cellular patches for cell-mediated tumoritropic delivery","volume":"4","author":"Cheng","year":"2010","journal-title":"ACS Nano"},{"key":"10.1016\/j.biomaterials.2015.11.016_bib52","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.jconrel.2014.03.050","article-title":"Cell-mediated delivery of nanoparticles: taking advantage of circulatory cells to target nanoparticles","volume":"190","author":"Anselmo","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.biomaterials.2015.11.016_bib53","first-page":"3637","article-title":"Nanoparticle-based delivery of small interfering RNA: challenges for cancer therapy","volume":"7","author":"Miele","year":"2012","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.biomaterials.2015.11.016_bib54","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1158\/2159-8290.CD-12-0429","article-title":"First-in-humans trial of an RNA interference therapeutic targeting VEGF and KSP in cancer patients with liver involvement","volume":"3","author":"Tabernero","year":"2013","journal-title":"Cancer Discov."},{"key":"10.1016\/j.biomaterials.2015.11.016_bib55","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.immuni.2013.07.005","article-title":"Deciphering and reversing tumor immune suppression","volume":"39","author":"Motz","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.biomaterials.2015.11.016_bib56","doi-asserted-by":"crossref","first-page":"767","DOI":"10.4049\/jimmunol.1103822","article-title":"Increased frequency of suppressive regulatory T cells and T cell-mediated antigen loss results in murine melanoma recurrence","volume":"189","author":"Jensen","year":"2012","journal-title":"J.\u00a0Immunol."}],"container-title":["Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961215009126?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961215009126?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T16:14:38Z","timestamp":1758903278000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0142961215009126"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":56,"alternative-id":["S0142961215009126"],"URL":"https:\/\/doi.org\/10.1016\/j.biomaterials.2015.11.016","relation":{},"ISSN":["0142-9612"],"issn-type":[{"value":"0142-9612","type":"print"}],"subject":[],"published":{"date-parts":[[2016,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hitchhiking nanoparticles: Reversible coupling of lipid-based nanoparticles to cytotoxic T lymphocytes","name":"articletitle","label":"Article Title"},{"value":"Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biomaterials.2015.11.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}